½ÃÀ庸°í¼­
»óǰÄÚµå
1581279

¼¼°èÀÇ ÁÂ¾à Æ÷Àå ½ÃÀå : Á¦Ç°, ¼ÒÀç, Çü»ó, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Suppository Packaging Market by Product (Blister Pack, Bottles, Container), Material (Aluminum, Biodegradable, Plastic), Shape, Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁÂ¾à Æ÷Àå ½ÃÀåÀº 2023³â¿¡ 2¾ï 5,833¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â¿¡´Â 2¾ï 7,422¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.19%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 9,340¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÂ¾à Æ÷Àå ½ÃÀåÀº ÀǾàǰ Æ÷Àå »ê¾÷ÀÇ Áß¿äÇÑ ºÎºÐÀ̸ç Á¾àÀÇ º¸È£, º¸Á¸ ¹× º¸Á¸ ±â°£ÀÇ ¿¬ÀåÀ̶ó´Â ¿ªÇÒ¿¡ ÀÇÇØ Á¤Àǵ˴ϴÙ. ÀÌ Æ÷ÀåÀº ¿Âµµ º¯È­ ¹× ½À±â¿Í °°Àº ȯ°æ ¿äÀÎÀ¸·ÎºÎÅÍ º¸È£ÇØ¾ß ÇÏ´Â Á¾àÀÇ µ¶Æ¯ÇÑ ¹°¸®Àû »óÅ ¶§¹®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ·Î, ƯÈ÷ °æ±¸ Åõ¿©³ª Áֻ簡 ÀûÇÕÇÏÁö ¾ÊÀº °æ¿ì, Á÷ÀåÀ̳ª Áú¿¡ »ç¿ëÇÏ´Â ¾àÁ¦¸¦ Àü´ÞÇÏ´Â ¿ëµµ¿¡ Çʿ伺ÀÌ ¹ß°ßµË´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â º´¿ø, Ŭ¸®´Ð, ÀçÅÃÄ¡·á ¹× ´Ù¾çÇÕ´Ï´Ù. ±Þ¼º ¹× ¸¸¼º Ä¡·á ¿ä¹ýÀÇ Á߿伺À» ¹Ý¿µÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ÀÇ·á ¼ö¿ä°¡ ³ô¾ÆÁö°í, ´Ù¾çÇÑ Åõ¾à ÇüŸ¦ ÇÊ¿ä·Î ÇÏ´Â °í·ÉÈ­, Áö¼Ó°¡´É¼º°ú ȯÀÚ ÆíÀǼºÀ» Áß½ÃÇÑ Ã·´Ü ÆÐŰ¡ ±â¼ú µîÀÌ ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º Æ÷Àå ¹× ¼Ò¾Æ¿ë Æ÷Àå°ú °°Àº ±â¼ú Çõ½ÅÀº ƯÈ÷ ±ÔÁ¦ ±Ô¹üÀÌ ¾ö°ÝÇÑ Áö¿ª¿¡¼­ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ±×·¯³ª Á¦Á¶ ºñ¿ë »ó½Â, Æ÷Àå ±âÁØ ¾ö°ÝÈ­, ¿øÀç·á °¡°Ý º¯µ¿ µî ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â °úÁ¦µµ ³²¾Æ ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ º»ÁúÀº ¿ªµ¿ÀûÀ̸ç, ²÷ÀÓ¾ø´Â ±â¼úÀÇ Áøº¸¿Í ¸ÅÀÏ ÁøÈ­ÇÏ´Â À§»ý ±ÔÁ¦¿¡ ´ëÇÑ ÄÄÇöóÀ̾ð½ºÀÇ Çʿ伺¿¡ Èû¾²°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß¿¡¼­ÀÇ »ç¾÷ È®´ë¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷Àº Áö¼Ó °¡´ÉÇÑ ¼ÒÀç, »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎ, µðÁöÅÐ Çコ ÃßÀû ½Ã½ºÅÛ°úÀÇ ÅëÇÕ¿¡ ÃÊÁ¡À» ¸ÂÃá Á¶»ç¿Í Çõ½ÅÀ» ½Ç½ÃÇØ¾ß ÇÕ´Ï´Ù. °Ô´Ù°¡ ÇコÄɾîÀÇ ¿ä±¸°¡ ÃæÁ·µÇÁö ¾ÊÀº ½ÅÈï ½ÃÀåÀ» °³Ã´ÇÔÀ¸·Î½á ´õ¿í ¼ºÀåÇÒ °¡´É¼ºÀÌ »ý±æÁöµµ ¸ð¸¨´Ï´Ù. Àü·«Àû Á¦¾ÈÀº »ý»ê È¿À²¼ºÀ» ³ôÀÌ°í µ¿½Ã¿¡ ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀÌ´Â ¼±ÁøÀûÀÎ Á¦Á¶ °øÁ¤¿¡ ´ëÇÑ ÅõÀÚ¸¦ Æ÷ÇÔÇϸç, À̴ ȯ°æ ģȭÀû ÀÎ °üÇàÀ¸·ÎÀÇ ¼¼°è º¯È­¿¡ ºÎÇÕÇÕ´Ï´Ù. µË´Ï´Ù. ¿ä¾àÇÏ¸é ½ÃÀå »óȲÀº À¯¸ÁÇÑ ¼ºÀå °æ·Î¸¦ º¸¿©ÁÖÁö¸¸ ¼º°ø ¿©ºÎ´Â ±ÔÁ¦ »óȲÀ» ¼º°øÀûÀ¸·Î ±Øº¹Çϰí Çõ½ÅÀ» ¼ö¶ôÇÏ¸ç ºñ¿ë °ü·Ã °úÁ¦¸¦ È¿°úÀûÀ¸·Î ÇØ°áÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¿¡ ´Þ·Á ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 2¾ï 5,833¸¸ ´Þ·¯
¿¹Ãø³â(2024) 2¾ï 7,422¸¸ ´Þ·¯
¿¹Ãø³â(2030) 3¾ï 9,340¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 6.19%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÁÂ¾à Æ÷Àå ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÁÂ¾à Æ÷Àå ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á÷Àå ¶Ç´Â Áú·ÎºÎÅÍÀÇ ¾àÁ¦ Åõ¿©¸¦ ÇÊ¿ä·Î ÇÏ´Â Áúȯ Áõ°¡
    • ³ë³â Àα¸ÀÇ È®´ë¿¡ ÀÇÇÑ, »ç¿ëÇϱ⠽¬¿î Åõ¾à Æ÷¸Ë¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Æ÷Àå ¼Ö·ç¼ÇÀÇ Á߿伺 Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °ø±Þ¸ÁÀÇ È¥¶õ¿¡ ÀÇÇÑ ¿øÀç·áÀÇ ÀÔ¼ö °ï¶õ°ú ºñ¿ë »ó½Â
  • ½ÃÀå ±âȸ
    • ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿äÀÇ ³ô¾Æ¿¡ ÀÇÇÑ ÁÂ¾à Æ÷Àå µðÀÚÀÎÀÇ Çõ½Å
    • Á¾à Ä¡·á¿Í Æ÷Àå ÀÇÁ¸µµ¸¦ ³ôÀÌ´Â ¸¸¼º Áúȯ Áõ°¡
    • Á¾à Á¦Ç°ÀÇ Ç°ÁúÀ» °¨½Ã, È®º¸Çϱâ À§ÇÑ ½º¸¶Æ® Æ÷Àå ±â¼úÀÇ ÅëÇÕ
  • ½ÃÀåÀÇ °úÁ¦
    • Á¾àÀÇ º¹ÀâÇÑ ½ÂÀÎ °úÁ¤°ú ºó¹øÇÑ ±ÔÁ¦ º¯°æ

Porter's Five Forces : ÁÂ¾à Æ÷Àå ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÁÂ¾à Æ÷Àå ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÁÂ¾à Æ÷Àå ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÁÂ¾à Æ÷Àå ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÁÂ¾à Æ÷Àå ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÁÂ¾à Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÁÂ¾à Æ÷Àå ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÁÂ¾à Æ÷Àå ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ÁÂ¾à Æ÷Àå ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Á÷Àå ¶Ç´Â Áú·ÎºÎÅÍÀÇ ¾àÁ¦ Åõ¿©¸¦ ÇÊ¿ä·Î ÇÏ´Â ÁúȯÀÇ ¹ß»ý·üÀÇ »ó½Â
      • °í·ÉÀÚ Àα¸ Áõ°¡¿¡ ÀÇÇØ »ç¿ëÇϱ⠽¬¿î ¾àÁ¦ ÇüÅ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Ù
      • Áö¼Ó°¡´ÉÇϰí ȯ°æÄ£È­ÀûÀÎ ÆÐŰÁö ¼Ö·ç¼ÇÀÇ Á߿伺ÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
    • ¾ïÁ¦¿äÀÎ
      • °ø±Þ üÀÎÀÇ È¥¶õ¿¡ ÀÇÇØ ¿øÀç·á°ø±ÞÀÌ Á¤Ã¼µÇ¾î ºñ¿ëÀÌ »ó½ÂÇϰí ÀÖ´Ù
    • ±âȸ
      • ¸ÂÃãÇü ÀÇ·á ¼ö¿ä Áõ°¡°¡ ÁÂ¾à Æ÷Àå µðÀÚÀÎÀÇ Çõ½ÅÀ» ÃßÁø
      • ¸¸¼º ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½Â¿¡ ÀÇÇØ Á¾࿡ ÀÇÇÑ Ä¡·á¿Í Æ÷Àå¿¡ÀÇ ÀÇÁ¸ÀÌ ³ô¾ÆÁö°í ÀÖ´Ù
      • Á¾à Á¦Ç°ÀÇ Ç°ÁúÀ» °¨½Ã, º¸ÁõÇϱâ À§ÇÑ ½º¸¶Æ® ÆÐŰ¡ ±â¼úÀÇ ÅëÇÕ
    • °úÁ¦
      • Á¾àÀÇ º¹ÀâÇÑ ½ÂÀÎ °úÁ¤°ú ºó¹øÇÑ ±ÔÁ¦ º¯°æ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ¼ÒÀç : ȯ°æ ģȭÀûÀ̰í Áö¼Ó °¡´ÉÇÑ Æ¯¼ºÀ»À§ÇÑ »ýºÐÇØ ¼º Àç·á ä¿ë
    • ÀÀ¿ë : ¾ÈÀü¼º°ú Æí¸®¼ºÀ» ¸ñÀûÀ¸·Î ÇÑ ÀǾàǰ ÀÀ¿ë ºÐ¾ß¿¡¼­ ÁÂ¾à Æ÷ÀåÀÇ Áß¿äÇÑ »ç¿ë
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÁÂ¾à Æ÷Àå ½ÃÀå : Á¦Ç°º°

  • ºí¸®½ºÅÍ ÆÑ
  • º´
  • ¿ë±â
  • ½ºÆ®¸³ ÆÑ
  • Æ©ºê

Á¦7Àå ÁÂ¾à Æ÷Àå ½ÃÀå : ¼ÒÀ纰

  • ¾Ë·ç¹Ì´½
  • »ýºÐÇØ¼º
  • ÇÃ¶ó½ºÆ½
    • Æú¸®¿¡Æ¿·»(PE)
    • Æú¸®ÇÁ·ÎÇÊ·»(PP)
    • Æú¸®¿°È­ºñ´Ò(PVC)
  • Æú¸®¸Ó Çʸ§
    • Æú¸®¾Æ¹Ìµå
    • Æú¸®¿¡½ºÅ׸£

Á¦8Àå ÁÂ¾à Æ÷Àå ½ÃÀå Çü»óº°

  • ¿ø»ÔÇü
  • ¿øÅëÇü
  • ´öºô
  • °è¶õÇü
  • ±¸Çü
  • ¾î·Ú

Á¦9Àå ÁÂ¾à Æ÷Àå ½ÃÀå : ¿ëµµº°

  • ±Í
  • ºñ°­
  • Á÷Àå
  • ¿äµµ
  • Áú

Á¦10Àå ÁÂ¾à Æ÷Àå ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø ¹× Ŭ¸®´Ð
  • ¾à±¹

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÁÂ¾à Æ÷Àå ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÂ¾à Æ÷Àå ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÂ¾à Æ÷Àå ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • EthypharmÀº ¸Þ»ì¶óÁø ÁÂÁ¦ÀÇ Àμö¿¡ ÀÇÇØ Áß±¹ÀÇ IBD ½ÃÀå¿¡¼­ÀÇ Á¦Ç° Á¦°øÀ» °­È­
    • Binnopharm group, ·¯½Ã¾ÆÀÇ Á¦·¹³ë±×¶óµå¿¡ ÀÖ´Â ºñ³ëÆÊ Á¦Á¶ °ÅÁ¡¿¡¼­ »õ·Î¿î ÁÂ¾à ¶óÀÎÀ» È®´ë
    • LGM Pharma´Â ºÐ¼® ½ÃÇè ¼­ºñ½º¸¦ È®´ëÇϰí CDMO ¼­ºñ½º¸¦ °­È­ÇÏ´Â »õ·Î¿î Á¾à Á¦Á¶ ´É·ÂÀ» µµÀÔÇϱâ À§ÇØ 200¸¸ ´Þ·¯ ÀÌ»óÀ» ÅõÀÚÇÕ´Ï´Ù.
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Amcor plc
  • Aphena Pharma Solutions Holdings, Inc.
  • AptarGroup, Inc.
  • Bayer AG
  • Catalent, Inc.
  • Clondalkin Group Holdings BV
  • Fresenius SE & Co. KGaA
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Hoffmann Neopac AG
  • Johnson & Johnson
  • Nipro Corporation
  • Novartis AG
  • Oliver Products Company
  • Pfizer
  • Printpack Holdings, Inc.
  • Roche Holding AG
  • Sanofi SA
  • Schott AG
  • Sealed Air Corporation
  • Sonoco Products Company
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Winpak Ltd.
BJH 24.11.07

The Suppository Packaging Market was valued at USD 258.33 million in 2023, expected to reach USD 274.22 million in 2024, and is projected to grow at a CAGR of 6.19%, to USD 393.40 million by 2030.

The suppository packaging market, an integral segment of the broader pharmaceutical packaging industry, is defined by its role in protecting, preserving, and extending the shelf life of suppository medications. This packaging is essential due to the unique physical state of suppositories, which require protection from environmental factors such as temperature fluctuations and moisture. Primarily, it finds necessity in applications for delivering medications for rectal or vaginal use, especially when oral administration or injections are not suitable. End-use scope spans across hospitals, clinics, and home care settings, reflecting its importance in both acute and chronic treatment regimens. Key factors influencing growth in this market include rising healthcare demands, an aging population requiring diverse medication forms, and advances in packaging technologies emphasizing sustainability and patient convenience. Innovations such as biodegradable and child-resistant packaging present lucrative opportunities, especially in regions with stringent regulatory norms. However, challenges persist, such as high production costs, stringent packaging standards, and fluctuating raw material prices which could hinder growth. The market's nature is dynamic, driven by constant technological advancements and the need for compliance with ever-evolving health regulations. For businesses looking to capitalize on this sector, research and innovation should focus on sustainable materials, user-friendly designs, and integration with digital health tracking systems. Additionally, tapping into emerging markets with unmet healthcare needs may offer further growth potential. A strategic recommendation includes investing in advanced manufacturing processes that enhance production efficiency while reducing environmental impacts, thereby aligning with the global shift towards greener practices. In sum, while the suppository packaging market presents promising growth avenues, success depends on navigating regulatory landscapes, embracing innovation, and addressing cost-related challenges effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 258.33 million
Estimated Year [2024] USD 274.22 million
Forecast Year [2030] USD 393.40 million
CAGR (%) 6.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Suppository Packaging Market

The Suppository Packaging Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of diseases requiring rectal or vaginal administration of medications
    • Expansion of the geriatric population leading to higher demand for easy-to-use medication formats
    • Growing emphasis on the importance of sustainable and environmentally-friendly packaging solutions
  • Market Restraints
    • Supply chain disruptions affecting raw material availability and increasing costs
  • Market Opportunities
    • Growing demand for personalized medicine driving innovation in suppository packaging designs
    • Rising prevalence of chronic diseases increasing reliance on suppository treatments and packaging
    • Integration of smart packaging technologies to monitor and ensure the quality of suppository products
  • Market Challenges
    • Complex approval process of suppositories and frequent changes in regulations

Porter's Five Forces: A Strategic Tool for Navigating the Suppository Packaging Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Suppository Packaging Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Suppository Packaging Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Suppository Packaging Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Suppository Packaging Market

A detailed market share analysis in the Suppository Packaging Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Suppository Packaging Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Suppository Packaging Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Suppository Packaging Market

A strategic analysis of the Suppository Packaging Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Suppository Packaging Market, highlighting leading vendors and their innovative profiles. These include Amcor plc, Aphena Pharma Solutions Holdings, Inc., AptarGroup, Inc., Bayer AG, Catalent, Inc., Clondalkin Group Holdings B.V., Fresenius SE & Co. KGaA, Gerresheimer AG, GlaxoSmithKline plc, Hoffmann Neopac AG, Johnson & Johnson, Nipro Corporation, Novartis AG, Oliver Products Company, Pfizer, Printpack Holdings, Inc., Roche Holding AG, Sanofi S.A., Schott AG, Sealed Air Corporation, Sonoco Products Company, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Winpak Ltd..

Market Segmentation & Coverage

This research report categorizes the Suppository Packaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blister Pack, Bottles, Container, Strip Pack, and Tubes.
  • Based on Material, market is studied across Aluminum, Biodegradable, Plastic, and Polymer Films. The Plastic is further studied across Polyethylene (PE), Polypropylene (PP), and Polyvinyl Chloride (PVC). The Polymer Films is further studied across Polyamide and Polyester.
  • Based on Shape, market is studied across Conical, Cylindrical, Duckbill, Ovate, Spherical, and Torpedo.
  • Based on Application, market is studied across Ear, Nasal, Rectal, Urethral, and Vaginal.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of diseases requiring rectal or vaginal administration of medications
      • 5.1.1.2. Expansion of the geriatric population leading to higher demand for easy-to-use medication formats
      • 5.1.1.3. Growing emphasis on the importance of sustainable and environmentally-friendly packaging solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Supply chain disruptions affecting raw material availability and increasing costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for personalized medicine driving innovation in suppository packaging designs
      • 5.1.3.2. Rising prevalence of chronic diseases increasing reliance on suppository treatments and packaging
      • 5.1.3.3. Integration of smart packaging technologies to monitor and ensure the quality of suppository products
    • 5.1.4. Challenges
      • 5.1.4.1. Complex approval process of suppositories and frequent changes in regulations
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Material: Adoption of biodegradable materials for eco-friendly and sustainable properties
    • 5.2.2. Application: Significant usage of suppository packaging in pharmaceutical application for safety and convenience
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Suppository Packaging Market, by Product

  • 6.1. Introduction
  • 6.2. Blister Pack
  • 6.3. Bottles
  • 6.4. Container
  • 6.5. Strip Pack
  • 6.6. Tubes

7. Suppository Packaging Market, by Material

  • 7.1. Introduction
  • 7.2. Aluminum
  • 7.3. Biodegradable
  • 7.4. Plastic
    • 7.4.1. Polyethylene (PE)
    • 7.4.2. Polypropylene (PP)
    • 7.4.3. Polyvinyl Chloride (PVC)
  • 7.5. Polymer Films
    • 7.5.1. Polyamide
    • 7.5.2. Polyester

8. Suppository Packaging Market, by Shape

  • 8.1. Introduction
  • 8.2. Conical
  • 8.3. Cylindrical
  • 8.4. Duckbill
  • 8.5. Ovate
  • 8.6. Spherical
  • 8.7. Torpedo

9. Suppository Packaging Market, by Application

  • 9.1. Introduction
  • 9.2. Ear
  • 9.3. Nasal
  • 9.4. Rectal
  • 9.5. Urethral
  • 9.6. Vaginal

10. Suppository Packaging Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Homecare Settings
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmacies

11. Americas Suppository Packaging Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Suppository Packaging Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Suppository Packaging Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Ethypharm enhances its offerings in the Chinese IBD market with acquisition of Mesalazine suppository
    • 14.3.2. Binnopharm group expands new suppository line at the Binnopharm manufacturing site in Zelenograd, Russia
    • 14.3.3. LGM Pharma invests over USD 2 million to expand analytical testing services and introduce new suppository manufacturing capabilities enhancing CDMO offerings
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amcor plc
  • 2. Aphena Pharma Solutions Holdings, Inc.
  • 3. AptarGroup, Inc.
  • 4. Bayer AG
  • 5. Catalent, Inc.
  • 6. Clondalkin Group Holdings B.V.
  • 7. Fresenius SE & Co. KGaA
  • 8. Gerresheimer AG
  • 9. GlaxoSmithKline plc
  • 10. Hoffmann Neopac AG
  • 11. Johnson & Johnson
  • 12. Nipro Corporation
  • 13. Novartis AG
  • 14. Oliver Products Company
  • 15. Pfizer
  • 16. Printpack Holdings, Inc.
  • 17. Roche Holding AG
  • 18. Sanofi S.A.
  • 19. Schott AG
  • 20. Sealed Air Corporation
  • 21. Sonoco Products Company
  • 22. Takeda Pharmaceutical Co. Ltd.
  • 23. Teva Pharmaceutical Industries Ltd.
  • 24. West Pharmaceutical Services, Inc.
  • 25. Winpak Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦